Primum non nocere: the onus to characterize the potential harms of psychedelic treatment / Sharmin Ghaznavi en The American Journal of Psychiatry, Año 2025 - Vol. 182 - No.1 (Enero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 47-53 Título : Primum non nocere: the onus to characterize the potential harms of psychedelic treatment Tipo de documento: texto impreso Autores: Sharmin Ghaznavi, Autor ; Jeremy N. Ruskin, Autor ; Stephen J. Haggerty, Autor Fecha de publicación: 2025 Artículo en la página: pp. 47-53 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Efectos adversos, Ética, Psicodélicos, Riesgos. Resumen: The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics. As with all therapeutic interventions, research is needed not only into their benefits but also potential risks. Link: ./index.php?lvl=notice_display&id=31558 [artículo] Primum non nocere: the onus to characterize the potential harms of psychedelic treatment [texto impreso] / Sharmin Ghaznavi, Autor ; Jeremy N. Ruskin, Autor ; Stephen J. Haggerty, Autor . - 2025 . - pp. 47-53. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 47-53 Palabras clave: Efectos adversos, Ética, Psicodélicos, Riesgos. Resumen: The last few years have seen exponential growth in interest, investment, advocacy, and research into psychedelics as therapeutics. This reflects an optimism about the potential promise of psychedelics as therapeutics. As with all therapeutic interventions, research is needed not only into their benefits but also potential risks. Link: ./index.php?lvl=notice_display&id=31558

---

1 (1 - 1 / 1)